| Recruiting | 1 | 1200 | Europe, Canada, Japan, US, RoW | Sotorasib, Trametinib, RMC-4630, Afatinib, Pembrolizumab, Panitumumab, Carboplatin, pemetrexed, docetaxel, paclitaxel, Atezolizumab, Palbociclib, MVASI® (bevacizumab-awwb), TNO155, IV Chemotherapy (Regimen 1), IV Chemotherapy (Regimen 2), BI 1701963, AMG 404, Everolimus | Amgen | Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation | 12/26 | 12/27 | | |